An Assessment of the Impact That Chemotherapy Treatment Has on Employment Status in Individuals with Lymphoma

A significant proportion of individuals undergoing treatment for lymphoma are of working age and are in employment prior to diagnosis and during subsequent chemotherapy treatment. This small-scale study seeks to explore the impact that chemotherapy treatments have on employment. Specifically, the re...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 108; no. 11; p. 5492
Main Authors Horn, Jeff, Shaw, Ann T.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 16.11.2006
Online AccessGet full text

Cover

Loading…
Abstract A significant proportion of individuals undergoing treatment for lymphoma are of working age and are in employment prior to diagnosis and during subsequent chemotherapy treatment. This small-scale study seeks to explore the impact that chemotherapy treatments have on employment. Specifically, the reasons for the decision to continue to work or not, and any perceived benefits or disadvantages encountered as a result are explored. Methods: All individuals presenting with newly diagnosed lymphoma, over a 12 month period, were identified retrospectively. Individuals of official working age, and who were receiving out-patient chemotherapy (i.e. who had the ability to be working at the time) were invited to participate. Participants were asked to complete a questionnaire that was designed to explore their experiences of employment during this time. Results: A total of 33 patients were invited to participate. A return rate of 70% was achieved. Of those who responded, 5 (22%) had already retired prior to diagnosis. A total of 12 patients (52%) continued to work during their chemotherapy treatment. Of these, 6 (50%) continued to work the same hours in the same conditions, whereas 6 (50%) worked an altered or flexible pattern. 6 patients (26%) stopped working for the duration of treatment, one of whom has not returned since. There were no obvious differences in patients with Hodgkin's Lymphoma as opposed to Non-Hodgkin's Lymphoma. The response rate was much higher in those who had received intravenous chemotherapy than oral preparations, preventing analysis of any potential variation in experiences. The qualitative data obtained gives a clearer insight into the many issues faced by the patient when undergoing chemotherapy treatment. Familiar themes were identified in many cases, and these were grouped into 5 main theme categories: Diversion from the reality of diagnosis and treatmentPsychological IssuesIssues of retained normalityPractical IssuesPhysical or medical issues. Difficulty in coping with the side-effects of treatment, particularly fatigue, were commonly cited. Emotional effects such as stress and anxiety were also alluded to. Despite this, those who continued to work reported benefit from retaining a normal lifestyle, gained support from co-workers and experienced a diversion of focus from treatment. Several of those who continued to work cited financial reasons for this decision. Feedback suggested that advice given by the health-care team was often lacking or inconsistent. This did not reflect our perception of current practice, so it may suggest that it is the way that information is given that is ineffective. Conclusion: The majority of patients continued to work during their treatment and there appear to be many benefits to this. Difficulties encountered related mainly to treatment side-effects, logistical and practical problems associated with undergoing chemotherapy. It is envisaged that a greater understanding of the impact that lymphoma and its treatment has on employment may improve the level of support that can be offered by the multi-disciplinary team. The curative nature of many Lymphomas demands that long-term complications of the disease and treatment are fully addressed at the time of diagnosis. Social, economic and employment welfare are integral aspects to be considered, especially in a group of individuals who are likely to be long-term survivors.
AbstractList A significant proportion of individuals undergoing treatment for lymphoma are of working age and are in employment prior to diagnosis and during subsequent chemotherapy treatment. This small-scale study seeks to explore the impact that chemotherapy treatments have on employment. Specifically, the reasons for the decision to continue to work or not, and any perceived benefits or disadvantages encountered as a result are explored. Methods: All individuals presenting with newly diagnosed lymphoma, over a 12 month period, were identified retrospectively. Individuals of official working age, and who were receiving out-patient chemotherapy (i.e. who had the ability to be working at the time) were invited to participate. Participants were asked to complete a questionnaire that was designed to explore their experiences of employment during this time. Results: A total of 33 patients were invited to participate. A return rate of 70% was achieved. Of those who responded, 5 (22%) had already retired prior to diagnosis. A total of 12 patients (52%) continued to work during their chemotherapy treatment. Of these, 6 (50%) continued to work the same hours in the same conditions, whereas 6 (50%) worked an altered or flexible pattern. 6 patients (26%) stopped working for the duration of treatment, one of whom has not returned since. There were no obvious differences in patients with Hodgkin’s Lymphoma as opposed to Non-Hodgkin’s Lymphoma. The response rate was much higher in those who had received intravenous chemotherapy than oral preparations, preventing analysis of any potential variation in experiences. The qualitative data obtained gives a clearer insight into the many issues faced by the patient when undergoing chemotherapy treatment. Familiar themes were identified in many cases, and these were grouped into 5 main theme categories: Diversion from the reality of diagnosis and treatment Psychological Issues Issues of retained normality Practical Issues Physical or medical issues. Difficulty in coping with the side-effects of treatment, particularly fatigue, were commonly cited. Emotional effects such as stress and anxiety were also alluded to. Despite this, those who continued to work reported benefit from retaining a normal lifestyle, gained support from co-workers and experienced a diversion of focus from treatment. Several of those who continued to work cited financial reasons for this decision. Feedback suggested that advice given by the health-care team was often lacking or inconsistent. This did not reflect our perception of current practice, so it may suggest that it is the way that information is given that is ineffective. Conclusion: The majority of patients continued to work during their treatment and there appear to be many benefits to this. Difficulties encountered related mainly to treatment side-effects, logistical and practical problems associated with undergoing chemotherapy. It is envisaged that a greater understanding of the impact that lymphoma and its treatment has on employment may improve the level of support that can be offered by the multi-disciplinary team. The curative nature of many Lymphomas demands that long-term complications of the disease and treatment are fully addressed at the time of diagnosis. Social, economic and employment welfare are integral aspects to be considered, especially in a group of individuals who are likely to be long-term survivors.
A significant proportion of individuals undergoing treatment for lymphoma are of working age and are in employment prior to diagnosis and during subsequent chemotherapy treatment. This small-scale study seeks to explore the impact that chemotherapy treatments have on employment. Specifically, the reasons for the decision to continue to work or not, and any perceived benefits or disadvantages encountered as a result are explored. Methods: All individuals presenting with newly diagnosed lymphoma, over a 12 month period, were identified retrospectively. Individuals of official working age, and who were receiving out-patient chemotherapy (i.e. who had the ability to be working at the time) were invited to participate. Participants were asked to complete a questionnaire that was designed to explore their experiences of employment during this time. Results: A total of 33 patients were invited to participate. A return rate of 70% was achieved. Of those who responded, 5 (22%) had already retired prior to diagnosis. A total of 12 patients (52%) continued to work during their chemotherapy treatment. Of these, 6 (50%) continued to work the same hours in the same conditions, whereas 6 (50%) worked an altered or flexible pattern. 6 patients (26%) stopped working for the duration of treatment, one of whom has not returned since. There were no obvious differences in patients with Hodgkin's Lymphoma as opposed to Non-Hodgkin's Lymphoma. The response rate was much higher in those who had received intravenous chemotherapy than oral preparations, preventing analysis of any potential variation in experiences. The qualitative data obtained gives a clearer insight into the many issues faced by the patient when undergoing chemotherapy treatment. Familiar themes were identified in many cases, and these were grouped into 5 main theme categories: Diversion from the reality of diagnosis and treatmentPsychological IssuesIssues of retained normalityPractical IssuesPhysical or medical issues. Difficulty in coping with the side-effects of treatment, particularly fatigue, were commonly cited. Emotional effects such as stress and anxiety were also alluded to. Despite this, those who continued to work reported benefit from retaining a normal lifestyle, gained support from co-workers and experienced a diversion of focus from treatment. Several of those who continued to work cited financial reasons for this decision. Feedback suggested that advice given by the health-care team was often lacking or inconsistent. This did not reflect our perception of current practice, so it may suggest that it is the way that information is given that is ineffective. Conclusion: The majority of patients continued to work during their treatment and there appear to be many benefits to this. Difficulties encountered related mainly to treatment side-effects, logistical and practical problems associated with undergoing chemotherapy. It is envisaged that a greater understanding of the impact that lymphoma and its treatment has on employment may improve the level of support that can be offered by the multi-disciplinary team. The curative nature of many Lymphomas demands that long-term complications of the disease and treatment are fully addressed at the time of diagnosis. Social, economic and employment welfare are integral aspects to be considered, especially in a group of individuals who are likely to be long-term survivors.
Author Horn, Jeff
Shaw, Ann T.
Author_xml – sequence: 1
  givenname: Jeff
  surname: Horn
  fullname: Horn, Jeff
  organization: Haematology Day Care Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom
– sequence: 2
  givenname: Ann T.
  surname: Shaw
  fullname: Shaw, Ann T.
  organization: Haematology Day Care Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom
BookMark eNqFUEFqwzAQFCWFJmnfUH3A6Uq2bPloQtoEAj007dUo8hqrxJaRlBT_vo7Tey-zzLAzDLMgs852SMgzgxVjkr8cT9ZWqy8GcuQrkeR8gjsyZ4LLCIDDjMwBII2SPGMPZOH9NwBLYi7mpC06WniP3rfYBWprGhqku7ZXOtBDowJdN9jaUXSqH-jBoQrT51Z5aju6afuTHSblI6hw9tR0dNdV5mKqszp5-mNCQ_dD2ze2VY_kvh5FfPq7S_L5ujmst9H-_W23LvaRZpDyCLNjPTYUMpaiVpqh4LHmIgbNkzjP6wozJUGDUEddiYrVKU8AlJRxKjFOk3hJsluudtZ7h3XZO9MqN5QMyutq5bRaeV1t5OV1sAlGZ3Fz4ljvYtCVXhvsNFbGoQ5lZc2_Gb84znqH
ContentType Journal Article
Copyright 2006 American Society of Hematology
Copyright_xml – notice: 2006 American Society of Hematology
DBID 6I.
AAFTH
AAYXX
CITATION
DOI 10.1182/blood.V108.11.5492.5492
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 5492
ExternalDocumentID 10_1182_blood_V108_11_5492_5492
S0006497118469315
GroupedDBID ---
-~X
.55
.GJ
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
6J9
9M8
AAEDW
AAFTH
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFFNX
AFOSN
AHPSJ
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
J5H
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
ZGI
0R~
AAYXX
ADVLN
AITUG
AKRWK
AMRAJ
CITATION
H13
ID FETCH-LOGICAL-c1062-e7bf00158385fac1e523c2530c24399fde7a80c05abcd5d1f62400a88368e3643
IEDL.DBID ABVKL
ISSN 0006-4971
IngestDate Fri Dec 06 00:57:59 EST 2024
Fri Feb 23 02:42:32 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This article is made available under the Elsevier license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1062-e7bf00158385fac1e523c2530c24399fde7a80c05abcd5d1f62400a88368e3643
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0006497118469315
PageCount 1
ParticipantIDs crossref_primary_10_1182_blood_V108_11_5492_5492
elsevier_sciencedirect_doi_10_1182_blood_V108_11_5492_5492
PublicationCentury 2000
PublicationDate 2006-11-16
PublicationDateYYYYMMDD 2006-11-16
PublicationDate_xml – month: 11
  year: 2006
  text: 2006-11-16
  day: 16
PublicationDecade 2000
PublicationTitle Blood
PublicationYear 2006
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0014325
Score 1.870328
Snippet A significant proportion of individuals undergoing treatment for lymphoma are of working age and are in employment prior to diagnosis and during subsequent...
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 5492
Title An Assessment of the Impact That Chemotherapy Treatment Has on Employment Status in Individuals with Lymphoma
URI https://dx.doi.org/10.1182/blood.V108.11.5492.5492
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB7yIEkvoXESmiY1cyi9KZa1WmmVm2wa7DopFJyQm1ivVsQHy6F2Dv73mVmtTAqFHnpZtAsDYmeY-WZ2HgBftQ1NWkZxoGIpglhyoMkkYRDNtMlSLbPKcr3z_c9k9BD_eJJPOzBsa2E4rdLr_kanO23tT3r-Nnsv8znX-JI5zVJCyOTiCS403-de5iTa-_ngcXK3fUyIRdQMMiDnmQl8mhch657LDr9-7IeK9tfcrcwtfzdS7wzP7Uc49ogR8-anTmDH1h04zWvylhcb_IYuh9MFxztwMGi_jobtJLcOHN77B_RTWOQ15ttmnLiskAAgjl2pJE6f9RqZzldlbXDapqHjSK9wWWMzINidMEx9XeG8xvG2qGuFHNfFuw3JyHKhz-Dh9vt0OAr8xIXAkGsYBTadVYyilFCy0qZvyU01kRShidhvqUqbahWaUOqZKWXZrxJOQdVKiURZQeDmHPbqZW0_AcZKmDDNCCKUSZwaoyoZGyGEtFkppBEXELZXXLw0jTUK55CoqHBcKZgrtC-YIW65gJuWFcUfMlKQ-v8X8ef_Ib6EDy70wul_yRXsrX-_2i8ERtazrhe2LuxOfqk3cpjbKw
link.rule.ids 314,780,784,27569,27924,27925,45663
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLYmEI8LggHijQ-IW1nXNG3KrUxMG2ycBuJWZWkqdliH2Djs3-Ok6QQSEgcuURPJUhVbzvc5dgxwJbWv4jwIPRFy5oXcBJpU5HvBWKokljwptKl3Hj5Fvefw4ZW_NqBT18KYtErn-yufbr21W2m53Wy9TyamxpeO0yQmhEwUj5lC83VCAxEZ-3p69_I4WF0mhCyoGhkQeTYCLs2LkHXLZoffvLR9QfMb81qZHX4_pL4dPN1d2HGIEdPqp_agocsm7KclseXpEq_R5nDa4HgTNu7qr61O3cmtCZtDd4G-D9O0xHT1GCfOCiQAiH1bKomjN7lAI-eqspY4qtPQsSfnOCuxahBsVwxM_ZzjpMT-qqhrjiaui4Ml2chsKg_guXs_6vQ813HBU0QNA0_H48KgKMEEL6Rqa6KpKuDMV4HhLUWuYyl85XM5VjnP20VkUlClECwSmhG4OYS1clbqI8BQMOXHCUGEPApjpUTBQ8UY4zrJGVfsGPx6i7P36mGNzBISEWRWK5nRCs0zoxA7HMNtrYrsh41k5P7_Ej75j_AlbPVGw0E26D89nsK2DcOYVMDoDNYWH5_6nIDJYnzhDO8LoLjdGw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Assessment+of+the+Impact+That+Chemotherapy+Treatment+Has+on+Employment+Status+in+Individuals+with+Lymphoma&rft.jtitle=Blood&rft.au=Horn%2C+Jeff&rft.au=Shaw%2C+Ann+T.&rft.date=2006-11-16&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=108&rft.issue=11&rft.spage=5492&rft.epage=5492&rft_id=info:doi/10.1182%2Fblood.V108.11.5492.5492&rft.externalDBID=n%2Fa&rft.externalDocID=10_1182_blood_V108_11_5492_5492
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon